PFIZER LIMITED;ZAHID ALI;KENNETH JOHN BUTCHER;RICHARD PHILIP BUTT;STEPHEN JOHN FELSTEAD;SOPHIE GLATT;RUTH MITCHELL MCKERNAN;MANINDER PANESAR
发明人:
申请号：
IL23217414
公开号：
IL232174D0
申请日:
2014.04.22
申请国别(地区):
IL
年份:
2014
代理人:
摘要：
The present invention is directed to 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide or a pharmaceutically acceptable salt thereof for the treatment of a disease associated with elevated blood uric acid levels, such as hyperuricemia or gout. The invention is also directed to the tosylate salt of 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide.
